Schrodinger
NASDAQ: SDGRNew York, US · Delaware corporation · 1 known investors
Schrödinger develops computational drug discovery and molecular simulation software for pharmaceutical and biotech companies.
Founders & leadership
TW
Timothy WrightDirector
MR
Murco RingnaldaExecutive Officer
RF
Ramy FaridExecutive Officer, Director
CA
Charles ArdaiDirector
JD
Joshua DistlerDirector
RF
Richard FriesnerDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$107.8MraisedMay 2019 · 13 investors · BiotechnologyRule 506(b)
▶$107.8MraisedMay 2019 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joel LebowitzExecutive Officer
- Rosana Kapeller-LiebermannDirector
- Cony D'CruzExecutive Officer
- Yvonne TranExecutive Officer
- Michael LyntonDirector
- Timothy WrightDirector
- Richard FriesnerDirector
- Ramy FaridExecutive Officer, Director
- Offering amount
- $115M
- Amount sold
- $107.8M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$22MraisedJun 2015 · 2 investors · BiotechnologyRule 506(b)
▶$22MraisedJun 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy WrightDirector
- Murco RingnaldaExecutive Officer
- Ramy FaridExecutive Officer, Director
- Charles ArdaiDirector
- Joshua DistlerDirector
- Richard FriesnerDirector
- Offering amount
- $22M
- Amount sold
- $22M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.